rolapitant 90 MG Oral Tablet
- RxCUI
- 1665503
- RxNorm name
- rolapitant 90 MG Oral Tablet
- Display name
- rolapitant 90 MG Oral Tablet
- Full name
- rolapitant 90 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:12
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Varubi | ROLAPITANT | Luria Therapeutics LLC | 8670c3cf-82d9-466d-be49-de33d8c8742b | 2026-09-08 | Warnings, Adverse reactions | 1665503 |
| Varubi | ROLAPITANT | TerSera Therapeutics LLC | a52896cd-4a98-49b8-82db-bf1985a64d97 | 2020-08-19 | Warnings, Adverse reactions | 1665503 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a52896cd-4a98-49b8-82db-bf1985a64d97 | rolapitant 90 MG Oral Tablet [PSN] · rolapitant 90 MG Oral Tablet [SCD] · rolapitant 90 MG (as 100 mg rolapitant HCl) Oral Tablet [SY] | 3 | 3 | These highlights do not include all the information needed to use VARUBI safely and effectively. See full prescribing information for VARUBI. VARUBI ® (rolapitant) tablets, for oral use Initial U.S. Approval: 2015 | 20200819 |